MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV), an advanced medical technologies company, today announced that it will be presenting the latest version of IV Clear™ at the Association for Vascular Access (“AVA”) Annual Scientific Meeting. In addition to the main event, Covalon will be one of a limited number of industry participants at the AVA Pediatric Special Interest Group’s pre-meeting educational workshop. IV Clear is the only dual antimicrobial clear silicone adhesive securement dressing that protects patients from bacteria and yeast, while also protecting them from unnecessary skin damage commonly found with the use of other vascular access dressings.
